𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Identification of genes with specific expression in pancreatic cancer by cDNA representational difference analysis

✍ Scribed by Thomas M. Gress; Christine Wallrapp; Marcus Frohme; Friederike Müller-Pillasch; Ulrike Lacher; Helmut Friess; Markus Büchler; Guido Adler; Jörg D. Hoheisel


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
100 KB
Volume
19
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis


cDNA representational difference analysis (cDNA-RDA) is a polymerase-chain-reaction-coupled subtractive and kinetic enrichment procedure for the isolation of differentially expressed genes. In this study, the technique was used to isolate novel genes specifically expressed in pancreatic cancer. cDNA-RDA was done on cDNA reverse transcribed from a poly(A)+ mRNA pool made from 10 cancer tissues (tester) by using as a driver a cDNA from a poly(A)+ mRNA pool made from a combination of 10 tissues of chronic pancreatitis and 10 healthy pancreatic tissues. The use of chronic pancreatitis in addition to healthy pancreas mRNA in the driver preparation eliminated the influence of stromal tissue components present as contamination in the cancer-specific preparations. Such cDNA-RDA led to the isolation of 16 distinct, cancer-specific gene fragments. These were confirmed to be overexpressed in pancreatic cancer tissues by Northern blot analysis. Sequence analysis revealed homologies to five genes previously implicated in the carcinogenesis of the pancreas or other tissues. Eleven fragments had no significant homology to any known gene and thus represent novel candidate disease genes. The experiments demonstrate that cDNA-RDA is a reproducible and highly efficient method for the identification of novel genes with cancer-specific expression.


📜 SIMILAR VOLUMES


Identification of amplified and expresse
✍ Jeremy Clark; Sandra Edwards; Megan John; Penny Flohr; Tony Gordon; Karine Maill 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 341 KB

## Abstract Microarray analysis using sets of known human genes provides a powerful platform for identifying candidate oncogenes involved in DNA amplification events but suffers from the disadvantage that information can be gained only on genes that have been preselected for inclusion on the array.

Identification of tissue-specific genes
✍ Bicheng Zhang; Xinmin Nie; Bingyi Xiao; Juanjuan Xiang; Shourong Shen; Jialei Go 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB 👁 1 views

## Abstract Suppression subtractive hybridization (SSH) was performed for isolation of tissue‐specific genes in nasopharyngeal epithelial tissue, by use of cDNAs from human adult nasopharyngeal epithelial tissue as tester and mixed cDNAs from esophagus, lung, liver, heart, stomach, spleen, skeletal

A novel region of amplification at 11p12
✍ Ralph Carvalho; Anya N. A. Milne; Mirjam Polak; G. Johan A. Offerhaus; Marian A. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 348 KB

## Abstract Diffuse‐type gastric carcinomas (GCs) are often difficult to characterize because of contamination of tumor samples by surrounding normal tissue. As such, information regarding chromosomal aberrations in this subtype of GCs is limited. In this study, we used representational difference

Methylation status of breast cancer resi
✍ Hirofumi Nakano; Yoichi Nakamura; Hiroshi Soda; Megumi Kamikatahira; Kanako Uchi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 483 KB 👁 1 views

## Abstract ## BACKGROUND Breast cancer resistance protein (BCRP) functions as a drug efflux transporter that mediates drug resistance. Topoisomerase I inhibitors, including 7‐ethyl‐10‐hydroxycamptothecin (SN‐38), are substrates effluxed by BCRP. However, it remains unclear whether the overexpress